EPIX Pharmaceuticals (NASDAQ: EPIX) announced that Bayer Schering Pharma will transfer the worldwide commercial rights for the novel blood pool ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE